000 01406 a2200385 4500
005 20250517012537.0
264 0 _c20150319
008 201503s 0 0 eng d
022 _a1944-7884
024 7 _a10.1097/QAI.0000000000000414
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFalasca, Francesca
245 0 0 _aDynamics of HIV DNA and residual viremia in patients treated with a raltegravir-containing regimen.
_h[electronic resource]
260 _bJournal of acquired immune deficiency syndromes (1999)
_cFeb 2015
300 _ae18-20 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-HIV Agents
_xtherapeutic use
650 0 4 _aDNA, Viral
_xblood
650 0 4 _aHIV
_xisolation & purification
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aPyrrolidinones
_xtherapeutic use
650 0 4 _aRaltegravir Potassium
650 0 4 _aViral Load
650 0 4 _aViremia
700 1 _aMazzuti, Laura
700 1 _aDʼEttorre, Gabriella
700 1 _aPaoletti, Francesca
700 1 _aTripolino, Omar
700 1 _aSerafino, Sara
700 1 _aAntonelli, Guido
700 1 _aTurriziani, Ombretta
773 0 _tJournal of acquired immune deficiency syndromes (1999)
_gvol. 68
_gno. 2
_gp. e18-20
856 4 0 _uhttps://doi.org/10.1097/QAI.0000000000000414
_zAvailable from publisher's website
999 _c24535362
_d24535362